[{"address1": "1111 Main Street", "address2": "Suite 660", "city": "Vancouver", "state": "WA", "zip": "98660", "country": "United States", "phone": "360 980 8524", "fax": "360 799 5954", "website": "https://www.cytodyn.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jacob P. Lalezari M.D.", "age": 64, "title": "CEO & Member of Scientific Advisory Board", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 356061, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Blok", "age": 37, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 399773, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cyrus  Arman M.B.A., Ph.D.", "age": 43, "title": "Senior Vice President of Business Operations", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 278100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert E. Hoffman B.B.A., C.P.A.", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bernie  Cunningham P.M.P., Ph.D.", "title": "Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Hansen Ph.D.", "title": "Head of Research & Basic Science", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Max  Lataillade D.O., M.P.H.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina  De Leon", "title": "Investors", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.32, "open": 0.318, "dayLow": 0.3001, "dayHigh": 0.318, "regularMarketPreviousClose": 0.32, "regularMarketOpen": 0.318, "regularMarketDayLow": 0.3001, "regularMarketDayHigh": 0.318, "payoutRatio": 0.0, "beta": 1.247, "trailingPE": "Infinity", "forwardPE": -1.7777777, "volume": 285320, "regularMarketVolume": 285320, "averageVolume": 2657174, "averageVolume10days": 1213390, "averageDailyVolume10Day": 1213390, "bid": 0.314, "ask": 0.316, "bidSize": 17084, "askSize": 29600, "marketCap": 394377568, "fiftyTwoWeekLow": 0.1, "fiftyTwoWeekHigh": 0.49, "fiftyDayAverage": 0.3366, "twoHundredDayAverage": 0.2237, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 346755008, "profitMargins": 0.0, "floatShares": 1231668892, "sharesOutstanding": 1232429952, "heldPercentInsiders": 0.0054900004, "heldPercentInstitutions": 0.00023, "impliedSharesOutstanding": 1232429952, "bookValue": -0.075, "lastFiscalYearEnd": 1717113600, "nextFiscalYearEnd": 1748649600, "mostRecentQuarter": 1740700800, "netIncomeToCommon": -8565000, "trailingEps": 0.0, "forwardEps": -0.18, "enterpriseToEbitda": 42.751, "52WeekChange": 1.2857144, "SandP52WeekChange": 0.13161862, "quoteType": "EQUITY", "currentPrice": 0.32, "recommendationKey": "none", "totalCash": 16400000, "totalCashPerShare": 0.013, "ebitda": 8111000, "totalDebt": 27317000, "quickRatio": 0.261, "currentRatio": 0.297, "returnOnAssets": 0.32154998, "freeCashflow": -47925376, "operatingCashflow": -4752000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CYDY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "CytoDyn Inc.", "longName": "CytoDyn Inc.", "fiftyDayAverageChange": -0.016600013, "fiftyDayAverageChangePercent": -0.049316734, "twoHundredDayAverageChange": 0.09629999, "twoHundredDayAverageChangePercent": 0.43048722, "priceToBook": -4.2666664, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1166020200000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.3001 - 0.318", "fullExchangeName": "OTC Markets OTCQB", "marketState": "CLOSED", "averageDailyVolume3Month": 2657174, "fiftyTwoWeekLowChange": 0.22, "fiftyTwoWeekLowChangePercent": 2.2, "fiftyTwoWeekRange": "0.1 - 0.49", "fiftyTwoWeekHighChange": -0.17000002, "fiftyTwoWeekHighChangePercent": -0.3469388, "fiftyTwoWeekChangePercent": 128.57144, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.0, "epsForward": -0.18, "corporateActions": [], "regularMarketTime": 1752796800, "exchange": "OQB", "messageBoardId": "finmb_10039157", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.32, "displayName": "CytoDyn", "trailingPegRatio": null, "__fetch_time": "2025-07-19"}]